Opinion

Video

Optimal Management Of Lupus Nephritis

Expert rheumatologists discuss current treatment options for lupus nephritis and emerging therapies with newer mechanisms of action.

0:00 Introduction

1:25 LN and its prognosis

3:20 Challenges due to varied presentations of LN

4:10 Traditional treatment paradigms

6:45 Challenges with management of LN

8:25 Classification of LN and its role in treatment

12:00 New treatments in LN

17:50 Anti-CD20 for treatment of LN

21:00 Combination therapy in clinical practice

22:45 Multidisciplinary care for LN

23:50 Guidelines in LN

26:00 Kidney biopsy in LN

27:15 Biomarkers for LN

28:30 Clinical outcomes in LN

31:30 JAK inhibitors in lupus and LN

34:00 Final thoughts

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.